And that means putting themselves at exceptional risk." What Is the FDA Reviewing at the July 2026 Peptide Meeting
Evidence supporting specific eradication strategies in SSc is limited, and no uniform treatment algorithm exists
1992;263:E106369
Disclosure of interest: Nothing to disclose Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.02 - ACUTE MANAGEMENT - Thrombolysis or thrombectomy P625 - ESOC25-894 IMPACT OF PYRAMIDAL TRACTS BEYOND ASPECTS ON CLINICAL OUTCOMES IN LARGE ISCHEMIC STROKE EVALUATED BEFORE ENDOVASCULAR THERAPY Satoshi Namitome 1 , Keisuke Kawamoto 1 , Yoichiro Nagao 2 , Seigo Shindo 1 , Tadashi Terasaki 1 , Makoto Nakajima 3 1 Japanese Red Cross Kumamoto Hospital, kumamoto, Japan, 2 Saiseikai Kumamoto Hospital, kumamoto, Japan, 3 Graduate School of Medical Sciences, Kumamoto University, kumamoto, Japan Background and Aims: In endovascular therapy for stroke with a large ischemic core, the Alberta Stroke Program Early Score (ASPECTS) and core volume evaluated by preoperative imaging are recognized as predictors of good clinical outcome
WE, MTAR, AAR, WAT, AAlo, MAB, and MA are employees at king abdulaziz medical city
.png)